Ardena has three European facilities including Ghent, Belgium, and Amsterdam and Assen, the Netherlands. Our expert teams based across our different sites collaborate closely every day, to ensure a seamless and integrated drug development pathway.
A team of around 75 employees work at our 1,600m2 GMP facility in Ghent. The site has a wide range of drug development and manufacturing capabilities, including:
- Formulation development
- Analytical development
- Stability studies
- GMP clinical supply manufacturing
- Clinical supply packaging and labeling
- Importing and releasing clinical supplies
- Technical & regulatory support
The facility is currently expanded to include 600m2 of additional laboratory facilities.
Our 850m2 GMP facility in Amsterdam includes purpose-built, state-of-the-art laboratories with 15 highly qualified research scientists specialising in solid state chemistry.
Our solid state chemistry capabilities include:
- Polymorph screening
- Salt screening
- Co-crystal screening
- Single crystal structure
From our facility in Amsterdam, we also provide crystallisation process development and analytical chemistry services, including particle engineering, solid form control, materials characterisation and intellectual property support.
Our Assen GLP-certified, 2000 m2 facility is home to a 40-strong team with specialist expertise in bio-analysis. The team is active during all phases of pharmaceutical R&D, from drug discovery to pre-clinical and all clinical phases, with services including:
- Bio-analysis, particularly LC-MS/MS and immunochemistry
- Drug screening (hit to lead)
- Logistics support for clinical multi-centre studies within Europe
Since 1969, the site has specialised in the analysis of endogenous (biomarkers) and exogenous (drugs) compounds in biological matrices derived from humans and animals.